Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL [Phase 2]
A phase 2 pilot study evaluating metformin therapy in patients with relapsed and untreated chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) [Phase 3]
Phase III study evaluating Panzyga for primary infection prophylaxis in chronic lymphocytic leukemia with hypogammaglobulinemia has complete…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors [Phase 3]
A Phase 3 study evaluating BGB-16673 versus investigator's choice in relapsed/refractory chronic lymphocytic leukemia or small lymphocytic l…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers [Phase 2]
This clinical trial update summarizes long-term safety data for pirtobrutinib in participants with previously treated blood cancers from a P…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL [Phase 1, Phase 2]
Phase I/II clinical trial update describing the study of Rapcabtagene Autoleucel in chronic lymphocytic leukemia, small lymphocytic lymphoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM) [Phase 1]
Phase 1 clinical trial update for MB-CART19.1 in CD19+ B-cell malignancies sponsored by Miltenyi Biomedicine GmbH. The study includes recurr…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies [Phase 1]
NX-5948 is being studied in a Phase 1 trial for adults with relapsed/refractory B-cell malignancies; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring [Phase 1]
Phase 1 rollover study by Janssen Research & Development to continue study treatment and ongoing safety monitoring in patients with acute my…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial update for customizing ibrutinib treatment regimens in previously untreated chronic lymphocytic leukemia and small lymphocytic…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T [Phase 1]
This clinical trial update reports long-term follow-up results from a Phase 1 study of CLBR001 CAR-T cells in relapsed/refractory B-cell lym…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial update evaluating ibrutinib as an immune-modulating agent for asymptomatic, high-risk chronic lymphocytic leukemia or small ly…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study [NA]
Completed clinical trial evaluating a geriatric optimization plan to improve survival in older adults undergoing allogeneic hematopoietic ce…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL [Phase 2]
A Phase 2 clinical trial evaluating venetoclax in combination with rituximab and hyaluronidase for relapsed/refractory chronic lymphocytic l…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia [Phase 3]
Phase 3 clinical trial evaluating autologous stem cell transplantation for chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies [Phase 1]
Phase 1 dosimetry and biodistribution study of the radiotracer [18F]-Fludarabine in untreated lymphoid malignancies, including chronic lymph…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Facing Obstacles to RDI (Relative Dose Intensity) Through Telephone Intervention Strategy [NA]
This completed study from University Hospital, Toulouse investigated the impact of a telephone-based intervention strategy on maintaining re…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 study evaluating ibrutinib in combination with obinutuzumab for relapsed or refractory Chronic Lymphocytic Leukemia. The trial is …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency [NA]
A completed clinical trial evaluated cholecalciferol (vitamin D3) in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma who …
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating pirtobrutinib for relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma is …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS [Phase 1, Phase 2]
Clinical trial update on the Phase 1/2 study of the duvelisib and venetoclax combination in relapsed or refractory Chronic Lymphocytic Leuke…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
A Phase 2 trial evaluating the combination of zanubrutinib and rituximab for previously untreated chronic lymphocytic leukemia or small lymp…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]
Phase 2 trial evaluating HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide is act…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML [Phase 1]
Phase 1 trial update for voruciclib alone or with venetoclax in various B-cell malignancies and acute myeloid leukemia; the study has been t…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of lenalidomide with DA-EPOCH-R in MYC-associated B-cell lymphomas has completed, and results hav…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: EHealth Educational Intervention to Improve Self-Management and Coping Behaviors Among Cancer Patients [NA]
A completed clinical trial evaluating an eHealth educational intervention to improve self-management and coping behaviors among cancer patie…